Tactile Systems Technology, Inc. (TCMD)
22.10
+0.39
(+1.80%)
USD |
NASDAQ |
Oct 02, 16:00
21.79
-0.31
(-1.40%)
After-Hours: 20:00
Tactile Systems Technology Enterprise Value : 446.21M for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 446.21M |
| October 01, 2026 | 437.35M |
| September 30, 2026 | 450.52M |
| September 29, 2026 | 455.97M |
| September 28, 2026 | 462.55M |
| September 25, 2026 | 460.51M |
| September 24, 2026 | 464.14M |
| September 23, 2026 | 453.70M |
| September 22, 2026 | 459.37M |
| September 21, 2026 | 463.23M |
| September 18, 2026 | 448.48M |
| September 17, 2026 | 456.65M |
| September 16, 2026 | 447.79M |
| September 15, 2026 | 455.51M |
| September 14, 2026 | 456.88M |
| September 11, 2026 | 453.02M |
| September 10, 2026 | 451.20M |
| September 09, 2026 | 444.39M |
| September 08, 2026 | 437.81M |
| September 04, 2026 | 440.98M |
| September 03, 2026 | 444.16M |
| September 02, 2026 | 453.24M |
| September 01, 2026 | 449.61M |
| August 31, 2026 | 466.18M |
| August 28, 2026 | 470.27M |
| Date | Value |
|---|---|
| August 27, 2026 | 469.13M |
| August 26, 2026 | 478.21M |
| August 25, 2026 | 479.80M |
| August 24, 2026 | 474.81M |
| August 21, 2026 | 485.25M |
| August 20, 2026 | 476.40M |
| August 19, 2026 | 480.26M |
| August 18, 2026 | 485.93M |
| August 17, 2026 | 502.73M |
| August 14, 2026 | 493.88M |
| August 13, 2026 | 482.75M |
| August 12, 2026 | 500.92M |
| August 11, 2026 | 492.74M |
| August 10, 2026 | 606.02M |
| August 07, 2026 | 614.19M |
| August 06, 2026 | 599.67M |
| August 05, 2026 | 625.09M |
| August 04, 2026 | 628.72M |
| August 03, 2026 | 620.55M |
| July 31, 2026 | 584.00M |
| July 30, 2026 | 584.68M |
| July 29, 2026 | 566.52M |
| July 28, 2026 | 574.24M |
| July 27, 2026 | 574.69M |
| July 24, 2026 | 568.34M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Treace Medical Concepts, Inc. | 313.82M |
| Abbott Laboratories | 196.37B |
| AngioDynamics, Inc. | 587.18M |
| Alphatec Holdings, Inc. | 2.040B |
| AtriCure, Inc. | 2.711B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 7.785M |
| Revenue (Quarterly) | 85.70M |
| Total Expenses (Quarterly) | 77.91M |
| EPS Diluted (Quarterly) | 0.3376 |
| Gross Profit Margin (Quarterly) | 75.50% |
| Profit Margin (Quarterly) | 9.08% |
| Earnings Yield | 4.91% |
| Operating Earnings Yield | 6.95% |
| Normalized Earnings Yield | 4.912 |